1-3 of 3
Maël Heiblig
Close
Sort by
Journal Articles

Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT

Carmelo Gurnari, Linda Koster, Laurien Baaij, Mael Heiblig, Ibrahim Yakoub-Agha, Matthew Collin, Jakob Passweg, Claude E. Bulabois, Anjum Khan, Michael Loschi, Fabrizio Carnevale-Schianca, Elena Crisà, Daniela Caravelli, Jürgen Kuball, Francesco Saraceni, Attilio Olivieri, Alessandro Rambaldi, Austin G. Kulasekararaj, Patrick J. Hayden, Manuela Badoglio, Francesco Onida, Christof Scheid, Franco Franceschini, Arsène Mekinian, Sinisa Savic, Maria Teresa Voso, Joanna Drozd-Sokolowska, John A Snowden, Kavita Raj, Tobias Alexander, Marie Robin, Raffaella Greco, Donal P. McLornan
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1444–1448.
https://doi.org/10.1182/bloodadvances.2023012478
Published: 2024
Includes: Supplemental data
Journal Articles

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study

Clinical Trials & Observations
Loïc Vasseur, Laurène Fenwarth, Jérôme Lambert, Stéphane de Botton, Martin Figeac, Céline Villenet, Maël Heiblig, Pierre-Yves Dumas, Christian Récher, Céline Berthon, Emilie Lemasle, Delphine Lebon, Juliette Lambert, Christine Terré, Karine Celli-Lebras, Hervé Dombret, Claude Preudhomme, Meyling Cheok, Raphael Itzykson, Nicolas Duployez
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4024–4034.
https://doi.org/10.1182/bloodadvances.2023010155
Published: 2023
Includes: Supplemental data
Journal Articles

Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience

Ava Diarra, Nicolas Duployez, Elise Fournier, Claude Preudhomme, Valérie Coiteux, Leonardo Magro, Bruno Quesnel, Maël Heiblig, Pierre Sujobert, Fiorenza Barraco, Marie Balsat, Quentin Scanvion, Eric Hachulla, David Launay, Ibrahim Yakoub-Agha, Louis Terriou,
Journal: Blood Advances
Blood Adv (2022) 6 (3): 998–1003.
https://doi.org/10.1182/bloodadvances.2021004749
Published: 2022
Includes: Supplemental data